These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27833317)

  • 1. Paraneoplastic syndrome turned out to be non-Hodgkin's lymphoma on
    Sahoo MK; Arunraj ST; Srivastava AK; Sahoo RK; Kumar R; Bal C
    Indian J Nucl Med; 2016; 31(4):292-294. PubMed ID: 27833317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
    Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria masquerading as relapse of Hodgkin's lymphoma on contrast enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: A diagnostic dilemma.
    Jeph S; Thakur K; Shamim SA; Aggarwal A
    Indian J Nucl Med; 2014 Apr; 29(2):102-4. PubMed ID: 24761064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?
    Fuster D; Chiang S; Andreadis C; Guan L; Zhuang H; Schuster S; Alavi A
    Nucl Med Commun; 2006 Jan; 27(1):11-5. PubMed ID: 16340718
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Bresler R; Schroeder HW; Chow DZ; Lim R
    World J Nucl Med; 2020; 19(2):124-130. PubMed ID: 32939199
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Harlos C; Metser U; Poon R; MacCrostie P; Mason W
    Curr Oncol; 2019 Aug; 26(4):e458-e465. PubMed ID: 31548813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
    Reinhardt MJ; Herkel C; Altehoefer C; Finke J; Moser E
    Ann Oncol; 2005 Sep; 16(9):1524-9. PubMed ID: 15946979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Workup of Suspected Classical Paraneoplastic Neurological Syndromes: A Systematic Review and Retrospective Analysis of
    Sundermann B; Schröder JB; Warnecke T; Heindel W; Schäfers M; Weckesser M; Buerke B
    Acad Radiol; 2017 Oct; 24(10):1195-1202. PubMed ID: 28551401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
    Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
    Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Human Immunodeficiency Virus Associated Non-Hodgkin's Lymphoma.
    Kung BT; Mak WS; Lau SM; Auyong TK; Tong CM
    World J Nucl Med; 2015; 14(1):53-6. PubMed ID: 25709547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?
    Saleh Farghaly HR; Mohamed Sayed MH; Nasr HA; Abdelaziz Maklad AM
    Indian J Nucl Med; 2015; 30(4):314-9. PubMed ID: 26430314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous Pancreatic Solid Pseudopapillary Neoplasm Masquerading as Extralymphatic Involvement on
    Teja Reddy SC; Reddy VV; Bhargavi D; Deepthi B; Tammineni S; Manthri R; Kalawat T
    Indian J Nucl Med; 2019; 34(4):309-312. PubMed ID: 31579234
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    García Vicente AM; Delgado-Bolton RC; Amo-Salas M; López-Fidalgo J; Caresia Aróztegui AP; García Garzón JR; Orcajo Rincón J; García Velloso MJ; de Arcocha Torres M; Alvárez Ruíz S;
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1575-1587. PubMed ID: 28550611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kimura Disease Simulating Hodgkin's Lymphoma on (18)F FDG PET-CT: Report of a Case.
    Yang TH; Chou YH; Kao WY; Cherng SC
    Nucl Med Mol Imaging; 2014 Dec; 48(4):313-6. PubMed ID: 26396638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET in malignant lymphoma: significance of positive findings.
    Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.
    Subramaniam RM; Shields AF; Sachedina A; Hanna L; Duan F; Siegel BA; Hillner BE
    Oncologist; 2016 Sep; 21(9):1079-84. PubMed ID: 27401896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma.
    Rodríguez-Vigil B; Gómez-León N; Pinilla I; Hernández-Maraver D; Coya J; Martín-Curto L
    Curr Probl Diagn Radiol; 2006; 35(4):151-63. PubMed ID: 16814002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.